Unsupervised, at-home use of transcranial direct current stimulation (tDCS) was no better than a sham control for treating a major depressive episode, a randomized trial showed. The PSYLECT trial of ...
SAN FRANCISCO and MALMO, Sweden, May 17, 2022 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Flow Neuroscience, creator of Europe's only medically ...
A recent clinical trial published in JAMA Psychiatry reveals disappointing results in testing the effectiveness of at-home transcranial direct current stimulation (tDCS). Researchers sought to explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results